down arrow

Laurus Labs

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
604.35
40.95 (7.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 21.01 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

570.20607.00

52 Week

386.85646.25
Valuation
Technical
Day's Volume

CASH

21.01 lacs (-23.93%) Volume

Shareholding (Dec 2024)

FII

25.56%

Held by 184 FIIs

DII

12.74%

Held by 38 DIIs

Promoter

27.62%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROCE of 18.89%

 
2

Poor long term growth as Operating profit has grown by an annual rate 8.90% of over the last 5 years

 
3

The company has declared positive results in Dec'2024 after 7 consecutive negative quarters

4

Stock is technically in a Mildly Bullish range

5

With ROCE of 5.2, it has a Expensive valuation with a 4.8 Enterprise value to Capital Employed

6

High Institutional Holdings at 38.3%

7

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 32,590 Cr (Large Cap)

stock-summary
P/E

152.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.14%

stock-summary
Debt Equity

0.66

stock-summary
Return on Equity

3.17%

stock-summary
Price to Book

7.35

Revenue and Profits (1 Year):
Net Sales:
1,415 Cr
(Quarterly Results - Dec 2024)
Net Profit:
92 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.14%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
27.49%
0.08%
27.57%
1 Year
31.7%
0.18%
31.88%
2 Years
99.79%
0.73%
100.52%
3 Years
0.42%
0.60%
1.02%
4 Years
43.3%
1.10%
44.4%
5 Years
633.43%
8.96%
642.39%

Latest dividend: 0.4 per share ex-dividend date: Nov-06-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.95%
EBIT Growth (5y)
8.90%
EBIT to Interest (avg)
8.78
Debt to EBITDA (avg)
1.75
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.97
Tax Ratio
29.85%
Dividend Payout Ratio
26.86%
Pledged Shares
2.69%
Institutional Holding
38.30%
ROCE (avg)
19.17%
ROE (avg)
19.29%
Valuation key factors
Factor
Value
P/E Ratio
152
Industry P/E
33
Price to Book Value
7.35
EV to EBIT
72.92
EV to EBITDA
37.81
EV to Capital Employed
4.82
EV to Sales
6.28
PEG Ratio
23.53
Dividend Yield
0.14%
ROCE (Latest)
5.21%
ROE (Latest)
3.17%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

2.6854

Mutual Funds

Held by 25 Schemes (7.62%)

FIIs

Held by 184 FIIs (25.56%)

Promoter with highest holding

M/s. Nsn Holdings (represented By Its Managing Partner, Dr. Satyanarayana Chava) (23.02%)

Highest Public shareholder

New World Fund Inc (6.5%)

Individual Investors Holdings

22.72%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 18.42% vs -22.65% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 298.88% vs -88.60% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,415.05",
          "val2": "1,194.92",
          "chgp": "18.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "285.15",
          "val2": "181.42",
          "chgp": "57.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.80",
          "val2": "50.82",
          "chgp": "13.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "92.30",
          "val2": "23.14",
          "chgp": "298.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.15%",
          "val2": "15.18%",
          "chgp": "4.97%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.51% vs -22.75% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -47.65% vs -87.23% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,418.61",
          "val2": "2,406.24",
          "chgp": "0.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "349.53",
          "val2": "354.59",
          "chgp": "-1.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "101.80",
          "val2": "81.58",
          "chgp": "24.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.35",
          "val2": "61.80",
          "chgp": "-47.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.45%",
          "val2": "14.74%",
          "chgp": "-0.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 6.46% vs -22.72% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 46.75% vs -87.64% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,833.66",
          "val2": "3,601.16",
          "chgp": "6.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "634.68",
          "val2": "536.01",
          "chgp": "18.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "159.60",
          "val2": "132.40",
          "chgp": "20.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "124.65",
          "val2": "84.94",
          "chgp": "46.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.56%",
          "val2": "14.88%",
          "chgp": "1.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -16.55% vs 22.39% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -79.68% vs -4.52% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,040.83",
          "val2": "6,040.55",
          "chgp": "-16.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "777.50",
          "val2": "1,592.19",
          "chgp": "-51.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "182.90",
          "val2": "165.17",
          "chgp": "10.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "160.55",
          "val2": "790.11",
          "chgp": "-79.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.42%",
          "val2": "26.36%",
          "chgp": "-10.94%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,415.05
1,194.92
18.42%
Operating Profit (PBDIT) excl Other Income
285.15
181.42
57.18%
Interest
57.80
50.82
13.73%
Exceptional Items
0.00
0.00
Consolidate Net Profit
92.30
23.14
298.88%
Operating Profit Margin (Excl OI)
20.15%
15.18%
4.97%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 18.42% vs -22.65% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 298.88% vs -88.60% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,418.61
2,406.24
0.51%
Operating Profit (PBDIT) excl Other Income
349.53
354.59
-1.43%
Interest
101.80
81.58
24.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
32.35
61.80
-47.65%
Operating Profit Margin (Excl OI)
14.45%
14.74%
-0.29%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 0.51% vs -22.75% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -47.65% vs -87.23% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,833.66
3,601.16
6.46%
Operating Profit (PBDIT) excl Other Income
634.68
536.01
18.41%
Interest
159.60
132.40
20.54%
Exceptional Items
0.00
0.00
Consolidate Net Profit
124.65
84.94
46.75%
Operating Profit Margin (Excl OI)
16.56%
14.88%
1.68%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 6.46% vs -22.72% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 46.75% vs -87.64% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
5,040.83
6,040.55
-16.55%
Operating Profit (PBDIT) excl Other Income
777.50
1,592.19
-51.17%
Interest
182.90
165.17
10.73%
Exceptional Items
0.00
0.00
Consolidate Net Profit
160.55
790.11
-79.68%
Operating Profit Margin (Excl OI)
15.42%
26.36%
-10.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -16.55% vs 22.39% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -79.68% vs -4.52% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Laurus Labs Ltd stock-summary
stock-summary
Laurus Labs Ltd
Large Cap
Pharmaceuticals & Drugs
Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology. The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others.
Company Coordinates stock-summary
Company Details
Plot No 21 Jawaharlal Nehru, Pharma City Parawada Visakhapatnam Andhra Pradesh : 531021
stock-summary
Tel: 91-891-3061222
stock-summary
http://www.lauruslabs.com
stock-summary
secretarial@lauruslabs.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."